Abbey Laboratories Pty Ltd v Bayer Australia Ltd

In the case of Abbey Laboratories Pty Ltd versus Bayer Australia Ltd, the dispute centred around the validity of a patent granted to Bayer. Abbey Laboratories, the patent opponent, contested the grant on various grounds including lack of support, novelty, and inventive step. The case was heard and determined in the Federal Court of Australia. The court was tasked with deciding whether the patent met the statutory requirements for novelty, inventive step, and sufficiency of disclosure.

The court first considered whether the patent was novel over the prior art. The opponent argued that the invention was not novel as it was an inevitable result of prior art. The court found that the invention did not introduce any new and useful principle or provide a solution that was not already known. Additionally, the court examined whether the invention involved an inventive step. It was determined that the invention did not involve any non-obvious step that would not have been obvious to a person skilled in the art. The court also assessed whether the patent sufficiently disclosed the invention. The opponent claimed that certain aspects were not sufficiently described, and the court agreed that the patent did not provide enough information for a person skilled in the art to replicate the invention.

Based on the findings, the court ruled that the patent did not meet the statutory requirements for novelty, inventive step, and sufficiency of disclosure. Consequently, the opposition was upheld, and the patent grant was revoked. The decision underscored the importance of meeting the rigorous standards set by patent law for novelty, inventiveness, and disclosure.